Soluble amyloid-β precursor peptide does not regulate GABA_B receptor activity.

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Secreted amyloid precursor protein (sAPP) modulates neuronal activity by interacting with cell surface receptors.
• Previous studies suggested sAPP and a derived peptide (APP17) bind to GABA_B receptors (GBRs) and mimic their inhibitory effects, proposing sAPP activates GBRs.

Purpose of the Study:

• To investigate whether APP17 and sAPP functionally activate classical GABA_B receptor signaling pathways.
• To determine if APP17 acts as a functional ligand for GBRs.

Main Methods:

• Binding assays to confirm APP17 affinity for GBRs.
• Biochemical and electrophysiological analyses in heterologous cells to assess GBR activity.
• In vitro and in vivo experiments to evaluate APP17 effects on synaptic GBR localization, GBR-activated currents, neurotransmitter release, and neuronal activity.

Main Results:

• APP17 demonstrated nanomolar affinity binding to GBRs.
• Biochemical and electrophysiological studies revealed APP17 does not influence GBR activity in heterologous cells.
• APP17 did not affect synaptic GBR localization, GBR-activated K+ currents, neurotransmitter release, or neuronal activity in vitro or in vivo.

Conclusions:

• APP17 is not a functional ligand for GABA_B receptors.
• The findings indicate that secreted APP (sAPP) exerts its neuronal effects through mechanisms independent of GABA_B receptor activation.